Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance
- PMID: 21353376
- DOI: 10.1016/j.eururo.2011.02.023
Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance
Abstract
Background: Active surveillance (AS) represents a treatment option for renal masses in patients who are not surgical candidates either because of existing comorbidities or patient choice. Among renal masses undergoing AS, some grow rapidly and require treatment or progress to metastatic disease. Patient and tumour characteristics related to this more aggressive behaviour have been poorly studied.
Objective: To report the analysis of a multi-institutional cohort of patients undergoing AS for small renal masses.
Design, setting, and participants: This prospective study included 82 patients with 84 renal masses who underwent AS in three Canadian institutions between July 2001 and June 2009.
Intervention: All patients underwent AS for renal masses presumed to be renal cell carcinoma (RCC) as based on diagnostic imaging.
Measurements: Age, sex, symptoms at presentation, maximum diameter at diagnosis (cm), tumour location (central/peripheral), degree of endophytic component (1-100%), and tumour consistency (solid/cystic) were used to develop a predictive model of the tumour growth rate using binary recursive partitioning analysis with a repeated measures outcome.
Results and limitations: With a median follow-up of 36 mo (range: 6-96), the mean annual renal mass growth rate for the entire cohort was 0.25 cm/yr (standard deviation [SD]: 0.49 cm/yr). Only one patient (1.2%) developed metastatic RCC. Amongst all variables, maximum diameter at diagnosis was the only predictor of tumour growth rate, and two distinct growth rates were identified. Masses that are ≥2.45 cm in largest diameter at diagnosis grow faster than smaller masses. This series was limited by its moderate sample size, although it is the largest published prospective series to date.
Conclusions: We confirm that most renal masses grow slowly and carry a low metastatic potential. Tumour size is a predictor of tumour growth rate, with renal masses <2.45 cm growing more slowly than masses >2.45 cm.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.Eur Urol. 2015 Sep;68(3):408-15. doi: 10.1016/j.eururo.2015.02.001. Epub 2015 Feb 16. Eur Urol. 2015. PMID: 25698065 Clinical Trial.
-
Active surveillance of renal masses: an analysis of growth kinetics and clinical outcomes stratified by radiological characteristics at diagnosis.Int Braz J Urol. 2014 Sep-Oct;40(5):627-36. doi: 10.1590/S1677-5538.IBJU.2014.05.07. Int Braz J Urol. 2014. PMID: 25498286
-
Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.BJU Int. 2013 May;111(6):872-9. doi: 10.1111/j.1464-410X.2012.11432.x. Epub 2012 Nov 13. BJU Int. 2013. PMID: 23145500
-
Explosive growth of a renal tumor during active surveillance.Can J Urol. 2013 Apr;20(2):6739-41. Can J Urol. 2013. PMID: 23587518 Review.
-
Renal mass size: concordance between pathology and radiology.Curr Opin Urol. 2013 Sep;23(5):389-93. doi: 10.1097/MOU.0b013e328363212b. Curr Opin Urol. 2013. PMID: 23778129 Review.
Cited by
-
Review of renal cell carcinoma and its common subtypes in radiology.World J Radiol. 2016 May 28;8(5):484-500. doi: 10.4329/wjr.v8.i5.484. World J Radiol. 2016. PMID: 27247714 Free PMC article. Review.
-
Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data.Curr Urol Rep. 2017 Feb;18(2):15. doi: 10.1007/s11934-017-0661-3. Curr Urol Rep. 2017. PMID: 28213859
-
Natural history of small renal masses.Chin Med J (Engl). 2015 May 5;128(9):1232-7. doi: 10.4103/0366-6999.156139. Chin Med J (Engl). 2015. PMID: 25947408 Free PMC article. Review.
-
Harnessing the Genomic Landscape of the Small Renal Mass to Guide Clinical Management.Eur Urol Focus. 2019 Nov;5(6):949-957. doi: 10.1016/j.euf.2019.04.011. Epub 2019 Apr 28. Eur Urol Focus. 2019. PMID: 31040082 Free PMC article. Review.
-
Natural history of Von Hippel-Lindau disease-associated and sporadic clear cell renal cell carcinoma: a comparative study.J Cancer Res Clin Oncol. 2022 Oct;148(10):2631-2641. doi: 10.1007/s00432-021-03806-0. Epub 2021 Oct 28. J Cancer Res Clin Oncol. 2022. PMID: 34709473 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials